John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
PUT
Home Depot
HD
$336B
| $3.57M | 0.02% |
27,000
+19,000
| +238% | +$2.42M |
|
802
MDU Resources
MDU
$4.21B
| $3.55M | 0.02% |
+509,151
| New | +$3.53M |
|
803
MidCap Financial Investment
MFIC
$798M
| $3.54M | 0.02% |
226,260
-13,679
| -6% | -$234K |
|
804
Matsons
MATX
$6.62B
| $3.54M | 0.02% |
83,068
+61,137
| +279% | +$2.85M |
|
805
PUT
Applied Materials
AMAT
$384B
| $3.53M | 0.02% |
189,000
+156,000
| +473% | +$2.71M |
|
806
CALL
Salesforce
CRM
$172B
| $3.53M | 0.02% |
45,000
+42,000
| +1,400% | +$3.28M |
|
807
State Street SPDR S&P Metals & Mining ETF
XME
$4.7B
| $3.52M | 0.02% |
+235,689
| New | +$3.94M |
|
|
YELL
808
DELISTED
Yellow Corporation Common Stock
YELL
| $3.52M | 0.02% |
+248,319
| New | +$3.9M |
|
|
AMRI
809
DELISTED
Albany Molecular Research Inc
AMRI
| $3.51M | 0.02% |
177,038
+142,867
| +418% | +$2.72M |
|
810
Delek US
DK
$4.18B
| $3.5M | 0.02% |
+142,430
| New | +$3.73M |
|
|
CCRN
811
DELISTED
Cross Country Healthcare
CCRN
| $3.49M | 0.02% |
212,683
+60,727
| +40% | +$966K |
|
812
QuidelOrtho
QDEL
$988M
| $3.47M | 0.02% |
163,651
+54,954
| +51% | +$1.12M |
|
|
SIR
813
DELISTED
SELECT INCOME REIT
SIR
| $3.46M | 0.02% |
397,688
-238,689
| -38% | -$2.1M |
|
814
Worthington Enterprises
WOR
$2.76B
| $3.45M | 0.02% |
185,875
-123,097
| -40% | -$2.28M |
|
815
PUT
Cisco
CSCO
$436B
| $3.45M | 0.02% |
127,000
+30,500
| +32% | +$842K |
|
816
AMERISAFE
AMSF
$488M
| $3.45M | 0.02% |
67,705
+51,159
| +309% | +$2.68M |
|
|
PTLA
817
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.44M | 0.02% |
+66,965
| New | +$3.25M |
|
818
Newmont
NEM
$138B
| $3.44M | 0.02% |
191,292
+158,145
| +477% | +$2.91M |
|
819
Universal Insurance Holdings
UVE
$1.22B
| $3.44M | 0.02% |
148,325
+110,477
| +292% | +$3.04M |
|
|
820
CALL
Applied Materials
AMAT
$384B
| $3.44M | 0.02% |
184,000
+152,000
| +475% | +$2.64M |
|
|
AYR
821
DELISTED
Aircastle Ltd
AYR
| $3.42M | 0.02% |
+163,901
| New | +$3.46M |
|
|
TTSH
822
DELISTED
Tile Shop Holdings
TTSH
| $3.42M | 0.02% |
208,470
+143,838
| +223% | +$2.18M |
|
823
Orthofix Medical
OFIX
$398M
| $3.41M | 0.02% |
86,970
+18,401
| +27% | +$687K |
|
|
HES
824
DELISTED
Hess
HES
| $3.41M | 0.02% |
+70,290
| New | +$3.99M |
|
|
AUO
825
DELISTED
AU Optronics Corp
AUO
| $3.41M | 0.02% |
1,170,580
+1,068,435
| +1,046% | +$3.05M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.